Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.
about
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death.Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death.Perspectives for cancer immunotherapy mediated by p19Arf plus interferon-beta gene transferImproving adenoviral vectors and strategies for prostate cancer gene therapy
P2860
Autoregulated expression of p53 from an adenoviral vector confers superior tumor inhibition in a model of prostate carcinoma gene therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Autoregulated expression of p5 ...... ostate carcinoma gene therapy.
@en
type
label
Autoregulated expression of p5 ...... ostate carcinoma gene therapy.
@en
prefLabel
Autoregulated expression of p5 ...... ostate carcinoma gene therapy.
@en
P2093
P2860
P1476
Autoregulated expression of p5 ...... rostate carcinoma gene therapy
@en
P2093
Eugenia Costanzi-Strauss
Rafael Bento da Silva Soares
Rodrigo Esaki Tamura
P2860
P304
P356
10.1080/15384047.2016.1235655
P577
2016-09-19T00:00:00Z